SCHEMBL6863093

SCHEMBL6863093

CCCCn1c(=O)[nH]c(N)c(C)c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.51
MAPT P10636 1/20 0.51
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 5/20 0.48
GAA P10253 4/20 0.48
PDE4A P27815 2/20 0.47
ADORA2A P29274 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
ADORA2B P29275 2/20 0.47
ADORA3 P0DMS8 1/20 0.47
LMNA P02545 1/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
USP2 O75604 2/20 0.44
POLB P06746 2/20 0.44
KEAP1 Q14145 2/20 0.44
NFE2L2 Q16236 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1945901 0.84 ATM (0.53) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL28179639 0.83 ATM (0.49) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL1943501 0.79 MAPT (0.47) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL1945724 0.79 ATM (0.48) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL1946776 0.74 MAPT (0.43) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL797375 0.73 MAPT (0.50) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL8098649 0.72 MAPT (0.55) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL18921074 0.72 ADORA2B (0.47) ATMMAPTKDM4EALDH1A1GAA
SCHEMBL8696414 0.71 TYMP (0.41) MAPTKDM4EALDH1A1GAAADORA2A
SCHEMBL2784423 0.71 ATM (0.53) ATMMAPTKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1444233-A2 A 2B? ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2004-08-11 EP disclosed
WO-2003042214-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2003-05-22 WO disclosed